Trial intelligence / Profile preview

Local vs intravenous tranexamic acid and phenylephrine for control of epistaxis bleeding

IRCT20120215009014N244Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of tranexamic acid and phenylephrine in epistaxis, sponsored by Hamadan University of Medical Sciences. Started Oct 2018; status: completed.

02

Drugs

tranexamic acidphenylephrine
03

Conditions

epistaxis

Beyond the preview

Go deeper on IRCT20120215009014N244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call